These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2671142)

  • 21. Comparative in-vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria.
    Shibl AM; Ishag AH; Durgham SM
    J Chemother; 1989 Jul; 1(4 Suppl):359-61. PubMed ID: 16312439
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004).
    Bouchillon SK; Hoban DJ; Johnson BM; Johnson JL; Hsiung A; Dowzicky MJ;
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):173-9. PubMed ID: 16105561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gram-negative bacillary pneumonia in the nosocomial setting. Role of aztreonam therapy.
    Cook JL
    Am J Med; 1990 Mar; 88(3C):34S-37S; discussion 38S-42S. PubMed ID: 2316557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Urinary infection. I. Comparative in vitro activities of several antibiotic drugs against Gram-negative bacteria].
    Giachino F; Allocco A; Tuninetti L; Tullio V; Cuffini AM; Carlone NA
    G Batteriol Virol Immunol; 1992 Jan-1993 Dec; 85(1-12):55-67. PubMed ID: 7498617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aztreonam in treatment of intra-abdominal infections.
    Malangoni MA
    Urology; 1988 Jun; 31(6 Suppl):28-32. PubMed ID: 3287747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative in vitro activity of imipenem and nine other antimicrobials against recently isolated pathogens.
    Bonadio M; Maccanti O; Cosci S; Giordani R
    J Chemother; 1989 Jul; 1(4 Suppl):58-60. PubMed ID: 16312303
    [No Abstract]   [Full Text] [Related]  

  • 27. Synergistic activity of amikacin with aztreonam against Pseudomonas aeruginosa and other gram-negative organisms.
    Greenberg RN; Bollinger M; Compton J
    Clin Ther; 1986; 8(3):354-8. PubMed ID: 3087621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aztreonam: a review of the first monobactam.
    Westley-Horton E; Koestner JA
    Am J Med Sci; 1991 Jul; 302(1):46-9. PubMed ID: 2063887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic interactions of ceftazidime, imipenem and aztreonam with amikacin in healthy volunteers.
    Adamis G; Papaioannou MG; Giamarellos-Bourboulis EJ; Gargalianos P; Kosmidis J; Giamarellou H
    Int J Antimicrob Agents; 2004 Feb; 23(2):144-9. PubMed ID: 15013039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of Ro 17-2301, a new monobactam, against gram-negative bacteria resistant to aminoglycosides.
    Landinez R; Garcia M; Merino C
    Chemioterapia; 1987 Jun; 6(2 Suppl):112-4. PubMed ID: 3509365
    [No Abstract]   [Full Text] [Related]  

  • 31. [Is aztreonam could become "a challenger" for treatment of Gram negative infections? May be an answer from microbiological data: in vitro study including 36,485 strains of enterobacteria and Pseudomonas].
    Honderlick P; Gravisse J; Dardelle D; Cahen P
    Pathol Biol (Paris); 2007 Dec; 55(10):475-7. PubMed ID: 17904768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of chemotherapeutic antagonism in opportunistic infections.
    Castelli M; Baggio G; Ruberto AI; Malagoli M; Casolari C; Rossi T; Galatulas I
    Anticancer Res; 1997; 17(6D):4339-44. PubMed ID: 9494530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibacterial effect of imipenem in vitro against important aerobic and anaerobic strains isolated from clinical specimens.
    Klietmann W; Focht J; Nösner K
    Chemioterapia; 1987 Aug; 6(4):243-50. PubMed ID: 3477332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parenteral carbapenems.
    Shah PM
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():175-80. PubMed ID: 18154543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of the in vitro activity of aztreonam on 1990 gram-negative bacterial strains recently isolated in Campania hospitals].
    Covelli I; Bolletti-Censi M; Fortunato A; Guarino A; Spagnoletti G; Amato G; Nani E; Anzivino D; Lavitola A; Gulletta E
    Boll Ist Sieroter Milan; 1986; 65(1):22-31. PubMed ID: 3521671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interpretive errors using an automated system for the susceptibility testing of imipenem and aztreonam.
    Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 1995 Jan; 21(1):57-60. PubMed ID: 7789099
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of the inhibitory and bactericidal activity of aztreonam and amikacin against gram negative aerobic bacilli.
    Fung-Tomc JC; Lincourt W; Thater C; Kessler RE
    Ann Clin Lab Sci; 1988; 18(6):463-7. PubMed ID: 3239949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative in vitro evaluation of BMY-28142, a new broad-spectrum cephalosporin, versus other beta-lactams against multiresistant gram-negative isolates.
    Giamarellou H; Sahin A; Chryssouli Z
    Drugs Exp Clin Res; 1987; 13(3):149-53. PubMed ID: 3622243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of the pharmacokinetics and pharmacodynamics of aztreonam.
    Ramsey C; MacGowan AP
    J Antimicrob Chemother; 2016 Oct; 71(10):2704-12. PubMed ID: 27334663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of monobactam antibiotics in surgical infections.
    DiPiro JT; Bowden TA
    Am J Surg; 1989 Jun; 157(6):607-14. PubMed ID: 2658643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.